PFIZER INC — Director's Dealing 2010

Mar 2, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2010-02-25

Reporting Person: KINDLER JEFFREY B (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-25	Common Stock	A	243482	—	Acquired	820888	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-25	Stock Appreciation Rights	$17.69	A	675676	Acquired	2015-02-25	Common Stock (675676)	Direct
2010-02-26	Phantom Stock Units SSP	$0	A	63	Acquired		Common Stock (63)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5051	Indirect
Common Stock	2350	Indirect
Common Stock	2350	Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The reporting person disclaims beneficial ownership of the shares held by such trusts.

F3: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F4: Each unit represents one phantom share of common stock.

F5: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.